Category: News

March 29, 2023

The results are compelling when compared with approved drugs known as GLP-1 agonists that showed a reduction of between 0.5% and 0.8% in A1C after four weeks of treatment, Jefferies analysts wrote in a note to clients. Biomea also has […]

March 28, 2023

Shares of Intra-Cellular Therapies rocketed up Tuesday morning, after the New York-based biotechnology company unveiled positive clinical trial results for a depression medication that some analysts called a “clear win.” The medication, known scientifically as lumateperone and commercially as Caplyta, […]

March 21, 2023

Obesity treatments represent a huge market opportunity for drugmakers. Some analysts have projected annual sales as high as $50 billion for effective treatments, and developers have recently been sprinting to capitalize. The race has been focused on drugs in Wegovy […]

March 21, 2023

An ongoing shortage of a drug for men with advanced prostate cancer is causing some patients to miss months of potentially life-extending treatment. The drug’s maker, Novartis Pharmaceuticals Corp., has said it can’t keep up with demand for the medication, […]

March 20, 2023

During a four-hour hearing last week that could eliminate nationwide access to a common and widely used abortion pill, federal Judge Matthew Kacsmaryk, of the Northern District of Texas, signaled his conservative Christian beliefs early and often. Speaking from the […]

March 15, 2023

Lyophilized PCR reaction bead reduces the cost of transport and extends shelf life for the test PBD Biotech has developed a lyophilized PCR reaction bead for its Actiphage blood test which identifies active tuberculosis (TB). The new function enables transportation […]

March 15, 2023

Jessica Layman estimates she has called more than 150 doctors in the past few years in her search for someone to prescribe opioids for her chronic pain. “A lot of them are straight-up insulting,” said the 40-year-old, who lives in […]

March 9, 2023

DRI Healthcare Trust, a prolific acquirer of drug royalties, is paying $100 million for a piece of a first-of-its-kind Type 1 diabetes drug. In an announcement Thursday, DRI said it bought royalties to the medicine, called Tzield and designed to […]

March 7, 2023

The decision to remove the previous 20% Ki-67 score requirement for patient selection means that those with HR-positive, HER2-negative early breast cancer can now be identified solely based on nodal status, tumour size and tumour grade. Jacob Van Naarden, chief […]

March 3, 2023

Clean Cells, part of the Clean Biologics group, a provider of biopharmaceutical product quality control services and manufacturer of starting materials, opened a new facility in Montaigu-Vendée, France, that will handle analytical activities. Clean Cells plans to recruit 20 new […]

February 27, 2023

Almost four years after becoming the first state to cap insulin copayments, Colorado may limit what consumers pay for epinephrine autoinjectors, also known as EpiPens, which treat serious allergic reactions. A proposed state law would cap out-of-pocket copays at $60 […]

February 24, 2023

The Swiss pharmaceutical giant Novartis, which has been shedding research programs as part of a broader restructuring, is now backing away from a prominent liver disease that, in recent years, captured much attention and investment from drugmakers. The disease, called […]

February 23, 2023

Moderna on Thursday reiterated its expectation that sales of its COVID-19 vaccine will total at least $5 billion in 2023, about a third of what the shot generated last year. The forecast, which matches guidance given by the biotechnology company […]

February 23, 2023

The CMS issued its statement late Wednesday following a request from the Alzheimer’s Association to reconsider its coverage policy on amyloid-clearing antibody drugs. The agency said its standards for coverage, that a drug is “reasonable and necessary,” differ from the […]

February 16, 2023

Talaris Therapeutics plans to dial back its research plans and restructure, the latest setback for a biotechnology company that’s been reeling since the death of a patient in a clinical trial last year. In a Thursday statement, Talaris said it’s […]

February 14, 2023

The term “molecular glue” has become a well-known phrase in oncology, and Crews is one of the reasons why. With his labmates at Yale, Crews has spent decades researching ways to repurpose the cell’s so-called garbage disposal system against cancer. […]

February 14, 2023

PureTech Health is cutting a small number of positions after a recent decision to deprioritize work on an early-stage drug delivery technology, a spokesperson for the biotechnology company creator confirmed to BioPharma Dive. PureTech, which has founded a handful of […]

February 13, 2023

Labcorp, a global life sciences company, has formed Fortrea, a spin-off of its clinical development business. Upon completion of the spin-off from Labcorp, Fortrea will operate as an independent, publicly traded global Contract Research Organization (CRO), that offers comprehensive drug […]

February 9, 2023

TVM Capital Life Science (TVM), a leading international venture capital firm focused on investments in life sciences innovation, announced an investment of up to $25 million in the newly formed U.S.-based biotechnology company, LAmAb Biologics (LAmAb), with its fund TVM […]

February 8, 2023

Americans received unprecedented access to health care during the pandemic, including hassle-free public insurance and free tests, treatments and vaccines for COVID-19. Now, they need to prepare for most of that to unwind, experts say. “Essentially, Congress and the administration […]